"To determine the impact of REV-ERBalpha activation in the cigarette smoke (CS)-induced lung inflammatory response we treated primary small airway epithelial cells with CS extract or lipopolysaccharide in the absence or presence of pre-treatment with the REV-ERBalpha agonist GSK 4112."xsd:string